Werkgroep Cardiologische centra Nederland English

COMMANDER (Follow up)

A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Oral Rivaroxaban with Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects with Chronic Heart Failure and Significant Coronary Artery Disease Following a Hospitalization for Exacerbation of Heart Failure.

Middel
rivaroxaban
Populatie
acuut coronair syndroom
Fase
III
Jaar aanvang
2013
Meer informatie
ClinicalTrials.gov

Studiedirecteur

dr. D.J.A. Lok (Cardioloog)
Deventer, Deventer Ziekenhuis